Johnson & Johnson stock faces resistance at $259.89 during consolidation: weekly analysis

Traders Union
All News
Stocks
Johnson & Johnson slips 0.72% this week

Highlights

Shares of Johnson & Johnson are down over the past week, now trading at $259.47 below key short-term moving averages.
Technical indicators such as MACD and Awesome Oscillator show a sell bias, with CCI moving into oversold territory and signals diverging.
Johnson & Johnson stock is expected to consolidate between $245.21 and $259.89, with a 65% probability of a decrease next week.

Talc charge and pharma gains reshape sentiment after Q3 results

Johnson & Johnson reported third-quarter revenue of $25.4 billion on October 13, 2026, reflecting a 5.9% year-over-year increase and revised its full-year guidance, according to CNBC and the company's official website. Earnings per share were sharply impacted by a one-time $5.5 billion special charge related to proposed talc litigation settlement, while adjusted EPS reached $2.59. Pharmaceutical sales posted solid growth, but the MedTech division grew more modestly. JNJ also declared a quarterly cash dividend of $1.34 per share, payable in December 2026.

Sell bias persists as consolidation range constrains technical momentum

The daily chart shows a contained move within a narrow range, with volatility at 7.72%. MACD and the Awesome Oscillator both indicate a sell bias, while CCI is in the oversold zone at -109.18, suggesting some divergence within momentum signals. Immediate resistance is set by the Ichimoku Kijun at $259.89, which is being tested, while support lies at $245.21. These levels define a consolidation phase as short-term pressure weighs on the stock.

Downside risk remains elevated pending breakout from consolidation zone

In the week ahead, Johnson & Johnson stock is expected to trade between $251 and $267.93, with a 35% probability of an increase and a 65% probability of a decrease. The likely base case is continued consolidation between $245.21 and $259.89. A bullish reversal would require a close above $259.89, while a break below $245.21 would open the door to further downside.

Anton Kharitonov, expert at Traders Union, sees Johnson & Johnson stock under pressure following a weekly pullback that pushed shares near $259. Technical signals on the daily chart remain mixed, with both MACD and the Awesome Oscillator on a sell bias, and the CCI deeply oversold at -109.18. This defensive setup is reinforced by immediate resistance from the Ichimoku Kijun at $259.89 and a support zone at $245.21, pointing to ongoing consolidation. Recent news highlighted stronger-than-expected third-quarter revenue but also a significant one-time $5.5 billion legal charge affecting bottom-line results. The base case for the coming week is for the stock to trade between $245.21 and $259.89, with odds still favoring further downside unless $259.89 is taken out. "Without a clear recovery above resistance, I remain cautious and focused on defense for the week ahead."

Earlier, analysts noted that Johnson & Johnson’s share price decline following earnings presented an entry point, emphasizing the company’s balance-sheet strength and consistent revenue growth. The current technical setup indicates a consolidation phase with oversold conditions, making the $259.89 resistance and $245.21 support pivotal levels to monitor for signs of either stabilization or renewed downside.

Source of Data: JNJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.